Agios Reports Third-Quarter Revenue of $55.39 Million, EPS Loss of $1.09
Revenue rose year over year and net loss narrowed, with higher product sales—primarily from the AQVESME launch—and lower research and development expenses outweighing increased commercial spending and lower interest income.
Revenue rose year over year, while net loss narrowed, as higher product sales—primarily from the AQVESME launch— and lower research and development expenses outweighed increased commercial spending and lower interest income.Financial Highlights¹ Reported as “Total revenue”. ² Reported as “Net loss”…